MedImmune And National Institutes Of Health Begin Clinical Testing Of A Live, Attenuated Intranasal Vaccine Against An H5N1 Avian Influenza Virus
submited by kickingbird at Jun, 16, 2006 16:18 PM from Medical News Today
MedImmune, Inc.(Nasdaq: MEDI) announced today that the National Institutes of Health (NIH)has begun enrolling participants in a Phase 1 study of an intranasal H5N1influenza vaccine candidate based on the company´s live, attenuated vaccinetechnology. [click link for full article]
See Also:
Latest news in those days:
- China: A human case of avian influenza A(H9N2) reported in Yunnan Province 1 days ago
- US: Highly Pathogenic Avian Influenza Detected in Texas Dairy Herd 5 days ago
- US: Dairy HPAI Detected in Cache County in Utah 5 days ago
- China: A human case of avian influenza A(H9N2) reported in Guangxi Zhuang Autonomous Region 7 days ago
- USDA: Confirms Highly Pathogenic Avian Influenza (H5N1) in a Dairy Herd in Idaho 12 days ago
[Go Top] [Close Window]
